Andrew Day is currently the Senior Director of Regulatory Excellence at AstraZeneca, where they lead a global delivery and enablement team of 50 experts focused on pharmacovigilance and regulatory compliance. In previous roles at AstraZeneca R&D, Andrew served as Director of Business Strategy and Planning, and as a Lean Sigma MBB and CI Leader from 2008 to 2011. Their earlier experience includes being a Solid Dose Technical Development Manager at Boots Contract Manufacturing from 2000 to 2002.
This person is not in the org chart
This person is not in any teams
This person is not in any offices